(0.06%) 5 472.78 points
(0.10%) 39 151 points
(0.38%) 17 785 points
(0.04%) $80.86
(-3.66%) $2.66
(-0.81%) $2 311.90
(0.16%) $28.92
(3.45%) $1 020.40
(0.27%) $0.936
(0.69%) $10.68
(0.43%) $0.792
(-0.27%) $87.25
Live Chart Being Loaded With Signals
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs...
Stats | |
---|---|
今日成交量 | 7 455 |
平均成交量 | 8 904 |
市值 | 13.81M |
EPS | $-0.580 ( Q2 | 2024-05-10 ) |
下一个收益日期 | ( $0 ) 2024-08-07 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.220 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.111 (2.58%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-03 | Nijhawan Pardeep | Buy | 4 785 | Common Shares |
2024-05-01 | Nijhawan Pardeep | Buy | 3 083 | Common Share |
2024-04-01 | Nijhawan Pardeep | Buy | 3 253 | Common Shares |
2024-03-25 | Nijhawan Pardeep | Buy | 5 000 | Common Shares |
2024-03-01 | Nijhawan Pardeep | Buy | 2 765 | Common Shares |
INSIDER POWER |
---|
77.80 |
Last 96 transactions |
Buy: 2 359 632 | Sell: 304 857 |
Edesa Biotech Inc 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Edesa Biotech Inc 财务报表
Annual | 2023 |
营收: | $0 |
毛利润: | $-183 471 (0.00 %) |
EPS: | $-2.93 |
FY | 2023 |
营收: | $0 |
毛利润: | $-183 471 (0.00 %) |
EPS: | $-2.93 |
FY | 2022 |
营收: | $0 |
毛利润: | $-118 188 (0.00 %) |
EPS: | $-1.050 |
FY | 2021 |
营收: | $0.00 |
毛利润: | $0.00 (0.00 %) |
EPS: | $-1.100 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Edesa Biotech Inc
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19 patients; and EB01, a topical treatment that is in Phase 2B clinical study for chronic allergic contact dermatitis. It has a license agreement with NovImmune SA to develop monoclonal antibodies targeting TLR4 and CXCL10. Edesa Biotech, Inc. was founded in 2015 and is headquartered in Markham, Canada.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。